| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8563468 | Complementary Therapies in Medicine | 2018 | 5 Pages |
Abstract
Our findings suggest that RYR, at the daily dose of 200â¯mg for 30â¯days, could be a promising agent to prevent and/or treat SGAs-induced hyperlipidemia. However, future adequately-powered and well-designed studies with long-term follow-up should evaluate RYR effectiveness, as an alternative option to statins, on the SGAs-induced metabolic side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Giulia Maria Troili, Edoardo Spina, Rocco Antonio Zoccali, Maria Rosaria Anna Muscatello,